Durable Orders More or Less in Line With Expectations.
Centene (CNC) shares surged more than 10% Friday morning as the managed care and health insurance provider's third-quarter results easily beat estimates as it boosted its membership rolls and premium
Centene Corporation (NYSE:CNC ) Q3 2024 Earnings Conference Call October 25, 2024 8:30 AM ET Company Participants Jennifer Gilligan - Senior Vice President, Finance and Investor Relations Sarah London
We don't expect much directional impetus in the stock market until after the presidential election is decided.
While the top- and bottom-line numbers for Centene (CNC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compar
Centene (CNC) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $2 per share a year ago.
On Friday, Centene Corporation  CNC third-quarter sales of $42.02 billion, up 10.5% year-over-year, beating the consensus of $37.69 billion.
The health insurer beat quarterly estimates for earnings and sales.
Centene reported a third quarter profit of $713 million as Obamacare enrollment and premium revenue helped overcome a big dip in Medicaid enrollment.
Chief Executive Sarah M. London said the company had navigated a ‘dynamic landscape' in the quarter amid turmoil in the Medicaid business.
Centene beat Wall Street estimates for third-quarter profit on Friday, as strength in its commercial insurance business outweighed the impact of high costs related to its government-backed Medicaid pl
-- Diluted E PS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80  -- Adjusted diluted EPS of $1.62 in the third quarter of 2024 .
Certain healthcare stocks rank among the “Harris trades,” meaning stocks that could rally on a win by Democratic presidential nominee Kamala Harris. Meanwhile, small-cap banks are among the stocks
CNC's third-quarter earnings are likely to have been affected by lower premiums and rising medical costs.
Centene, a leading health insurer, shows strong fundamentals and growth despite sector challenges, making it a "Buy" at a target price of $70/share. The company's 2Q24 results indicate robust earnings
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE